Top compounds associated with response to RBM20


Feature Type Standardized
Nominal ANOVA
mRNA clofarabine CTRPv2 pan-cancer AAC 0.05 0.1
mRNA erastin CTRPv2 pan-cancer AAC 0.059 0.1
mRNA sitagliptin CTRPv2 pan-cancer AAC -0.12 0.1
mRNA AS605240 GDSC1000 pan-cancer AAC -0.056 0.1
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.054 0.1
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.067 0.1
mRNA JW-480 CTRPv2 pan-cancer AAC 0.063 0.1
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
mRNA XL-184 GDSC1000 pan-cancer AAC -0.058 0.1
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.1
Download CSV